McCreedy Ellen M, Kane Robert L, Gollust Sarah E, Shippee Nathan D, Clark Kirby D
From the Division of Health Policy and Management, University of Minnesota School of Public Health, Minneapolis (EMM, SEG, NDS); University of Minnesota School of Public Health, Minneapolis (RLK); and the Department of Family Medicine and Community Health, University of Minnesota Medical School, Minneapolis (KDC).
J Am Board Fam Med. 2018 Mar-Apr;31(2):192-200. doi: 10.3122/jabfm.2018.02.170141.
Clinicians strive to deliver individualized, patient-centered care. However, these intentions are understudied. This research explores how patient characteristics associated with an high risk-to-benefit ratio with hypoglycemia medications affect decision making by primary care clinicians.
Using a vignette-based survey, we queried primary care clinicians on their intended management of geriatric patients with diabetes. The patients' ages, disease durations, and comorbidities were systematically varied. Clinicians indicated whether they would intensify glycemic control by adding a second-line hypoglycemia medication.
A convenience sample of 336 primary care clinicians completed the survey. Despite the recommendations for HbA targets <8% for more complex patients, an 80-year-old woman with an HbA of 7.5%, longstanding diabetes, coronary disease, and cognitive impairment and with instrumental activity of daily living dependencies, had a predicted probability of treatment intensification of 35%. Internists were 11% and nurse practitioners were 14% more likely to intensify treatment than family physicians ( < .01). These provider differences remained significant after controlling for geographic differences in treatment intensification. Providers in Florida were more likely to intensify treatment ( < .01).
Primary care clinicians often chose to intensify glycemic control despite individual patient factors that warrant higher glycemic targets based on existing guidelines. This research identifies possible missed opportunities for patient-centered goal setting and raises questions about the influence of training and practice environment on clinical decision making.
临床医生努力提供个性化的、以患者为中心的医疗服务。然而,这些意图尚未得到充分研究。本研究探讨了与低血糖药物高风险效益比相关的患者特征如何影响初级保健临床医生的决策。
我们通过基于 vignette 的调查,询问初级保健临床医生对老年糖尿病患者的预期管理。系统地改变患者的年龄、病程和合并症。临床医生指出他们是否会通过添加二线低血糖药物来强化血糖控制。
336 名初级保健临床医生的便利样本完成了调查。尽管对于更复杂的患者,推荐糖化血红蛋白(HbA)目标<8%,但一名 80 岁女性,HbA 为 7.5%,患有长期糖尿病、冠心病和认知障碍,且在日常生活工具性活动方面存在依赖,其强化治疗的预测概率为 35%。内科医生强化治疗的可能性比家庭医生高 11%,执业护士比家庭医生高 14%(P<0.01)。在控制治疗强化的地理差异后,这些医疗服务提供者之间的差异仍然显著。佛罗里达州的医疗服务提供者更有可能强化治疗(P<0.01)。
尽管根据现有指南个别患者因素表明应设定更高的血糖目标,但初级保健临床医生通常仍选择强化血糖控制。本研究确定了以患者为中心的目标设定可能错失的机会,并提出了关于培训和实践环境对临床决策影响的问题。